{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:32:12Z","timestamp":1793496732459,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.imlet.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:27:35Z","timestamp":1517560055000},"page":"52-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The role of gut microbiota and IL-23\/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates"],"prefix":"10.1016","volume":"196","author":[{"given":"Farhad","family":"Babaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Hasankhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rezaiemanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Babaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.imlet.2018.01.014_bib0005","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.0105-2896.2009.00852.x","article-title":"Genetics and genomics of ankylosing spondylitis","volume":"233","author":"Thomas","year":"2010","journal-title":"Immunol. Rev."},{"issue":"9570","key":"10.1016\/j.imlet.2018.01.014_bib0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrrheum.2014.181","article-title":"The changing clinical picture and epidemiology of spondyloarthritis","volume":"11","author":"Van Tubergen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.014_bib0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"HLA-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0035","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/rheumatology\/kes061","article-title":"The link between HLA-B27 and SpA\u2014new ideas on an old problem","volume":"51","author":"McHugh","year":"2012","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00296-015-3414-y","article-title":"Gut inflammation and microbiome in spondyloarthritis","volume":"36","author":"Kabeerdoss","year":"2016","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","article-title":"The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","article-title":"The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis","volume":"26","author":"Yeremenko","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.imlet.2018.01.014_bib0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Burton","year":"2007","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0060","doi-asserted-by":"crossref","first-page":"e17160","DOI":"10.1371\/journal.pone.0017160","article-title":"The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans","volume":"6","author":"Di Meglio","year":"2011","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.imlet.2018.01.014_bib0065","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1073\/pnas.1017854108","article-title":"Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses","volume":"108","author":"Sarin","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/ard.2010.133322","article-title":"Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese","volume":"70","author":"Davidson","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2013.06.010","article-title":"The critical role of interleukin-23 in spondyloarthropathy","volume":"57","author":"Sherlock","year":"2014","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0080","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0085","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar4228","article-title":"Microbes, the gut and ankylosing spondylitis","volume":"15","author":"Costello","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci","volume":"42","author":"Reveille","year":"2010","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the Immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0105","doi-asserted-by":"crossref","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet."},{"issue":"5393","key":"10.1016\/j.imlet.2018.01.014_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/242121a0","article-title":"Human lymphocyte antigen association in ankylosing spondylitis","volume":"242","author":"Caffrey","year":"1973","journal-title":"Nature"},{"issue":"7809","key":"10.1016\/j.imlet.2018.01.014_bib0115","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"301","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.imlet.2018.01.014_bib0120","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","article-title":"HLA-B27 and its subtypes in world populations","volume":"7","author":"Khan","year":"1995","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.55.4.268","article-title":"HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom","volume":"55","author":"Brown","year":"1996","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/BOR.0b013e32836203ab","article-title":"Structural and dynamic features of HLA-B27 subtypes","volume":"25","author":"Uchanska-Ziegler","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11926-013-0362-y","article-title":"Polymorphism of HLA-B27: 105 subtypes currently known","volume":"15","author":"Khan","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0145","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.39567","article-title":"Increased conformational flexibility of HLA-B*27 subtypes associated with ankylosing spondylitis","volume":"68","author":"Loll","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0150","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.38644","article-title":"HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis","volume":"66","author":"Jeanty","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbapap.2004.09.011","article-title":"The oxytocinase subfamily of M1 aminopeptidases","volume":"1751","author":"Tsujimoto","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"6906","key":"10.1016\/j.imlet.2018.01.014_bib0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature01074","article-title":"ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum","volume":"419","author":"Serwold","year":"2002","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0165","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.3390\/ijms13078338","article-title":"Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer","volume":"13","author":"Cifaldi","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0170","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3899\/jrheum.100019","article-title":"Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms","volume":"37","author":"Haroon","year":"2010","journal-title":"J. Rheumatol."},{"issue":"49","key":"10.1016\/j.imlet.2018.01.014_bib0175","doi-asserted-by":"crossref","first-page":"19890","DOI":"10.1073\/pnas.1309781110","article-title":"Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses","volume":"110","author":"Zervoudi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/annrheumdis-2014-206996","article-title":"Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis","volume":"75","author":"Chen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.13020","article-title":"The interplay between HLA-B27 and ERAP1\/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis","volume":"190","author":"Vitulano","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/08916934.2013.819855","article-title":"Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens","volume":"46","author":"Seregin","year":"2013","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0195","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","article-title":"CD8\u03b1\u03b2 T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats","volume":"170","author":"May","year":"2003","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0200","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondylarthritis in HLA-B27\/human \u03b22-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","article-title":"High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.38963","article-title":"Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA\u2013B27 allotypes","volume":"67","author":"Schittenhelm","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0215","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","article-title":"Autoantibodies against CD74 in spondyloarthritis","volume":"73","author":"Baerlecken","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1357-4310(00)01699-3","article-title":"HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?","volume":"6","author":"Colbert","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.imlet.2018.01.014_bib0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrfmmm.2004.06.056","article-title":"ER stress and the unfolded protein response","volume":"569","author":"Schr\u00f6der","year":"2005","journal-title":"Mutat. Res.\/Fundam. Mol. Mech. Mutagenesis"},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0235","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/eji.200737882","article-title":"Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-\u03b2 induction via X-box binding protein 1","volume":"38","author":"Smith","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"41","key":"10.1016\/j.imlet.2018.01.014_bib0245","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.1073\/pnas.1011736107","article-title":"Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression","volume":"107","author":"Goodall","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/annrheumdis-2013-204170","article-title":"No evidence for a critical role of the unfolded protein response in synovium and blood of patients with ankylosing spondylitis","volume":"73","author":"Neerinckx","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0255","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/14397595.2016.1259716","article-title":"Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23","volume":"27","author":"Rezaiemanesh","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0260","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","article-title":"Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation","volume":"73","author":"Ciccia","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9783","key":"10.1016\/j.imlet.2018.01.014_bib0265","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","article-title":"HLA-B27 misfolding and ankylosing spondylitis","volume":"57","author":"Colbert","year":"2014","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0275","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/annrheumdis-2016-209512","article-title":"Position 97 of HLA-B, a residue implicated in pathogenesis of ankylosing spondylitis, plays a key role in cell surface free heavy chain expression","volume":"76","author":"Chen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0280","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/eji.200323678","article-title":"Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling","volume":"33","author":"Bird","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/eji.200635997","article-title":"Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide","volume":"37","author":"Kollnberger","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0290","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.4049\/jimmunol.1102711","article-title":"HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I","volume":"188","author":"Giles","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0295","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","article-title":"Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis","volume":"186","author":"Bowness","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/14656566.2017.1284793","article-title":"New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents","volume":"18","author":"Toussirot","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0310","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.30593","article-title":"Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response","volume":"63","author":"Zeng","year":"2011","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0315","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis. Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0320","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10067-010-1646-5","article-title":"Th-17 associated cytokines in patients with reactive arthritis\/undifferentiated spondyloarthropathy","volume":"30","author":"Singh","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/BOR.0000000000000301","article-title":"Targeting the interleukin-23\/17 axis in axial spondyloarthritis","volume":"28","author":"Paine","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0330","first-page":"81","article-title":"Genetics of ankylosing spondylitis-insights into pathogenesis, Nature reviews","volume":"12","author":"Brown","year":"2016","journal-title":"Rheumatology"},{"issue":"7539","key":"10.1016\/j.imlet.2018.01.014_bib0335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-015-0805-0","article-title":"Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes","volume":"18","author":"Tseng","year":"2016","journal-title":"Arthritis. Res. Ther."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08916934.2014.976630","article-title":"Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice","volume":"48","author":"Ebihara","year":"2015","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0350","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2015.01.001","article-title":"The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels","volume":"164","author":"Babaloo","year":"2015","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0355","first-page":"202","article-title":"Interleukin-17A and interleukin-17F mRNA expressions in peripheral blood mononuclear cells of patients with multiple sclerosis","volume":"7","author":"Babaloo","year":"2010","journal-title":"Iran J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0360","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-[gamma] t+ CD3+ CD4-CD8-entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0365","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","article-title":"\u03b2-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice","volume":"64","author":"Ruutu","year":"2012","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0370","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","article-title":"Interleukin-23 mediates the intestinal response to microbial \u03b2-1, 3-glucan and the development of spondyloarthritis pathology in SKG mice","volume":"66","author":"Benham","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0375","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.autrev.2017.10.004","article-title":"Interleukin-22 in human inflammatory diseases and viral infections","volume":"16","author":"Shabgah","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"10089","key":"10.1016\/j.imlet.2018.01.014_bib0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0385","doi-asserted-by":"crossref","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","article-title":"Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0390","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","article-title":"Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis","volume":"60","author":"Shen","year":"2009","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0395","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","article-title":"Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis","volume":"64","author":"Kenna","year":"2012","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0400","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","article-title":"Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis","volume":"74","author":"Wendling","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0405","first-page":"17362","article-title":"Elevated serum levels of IL-6 and IL-17 may associate with the development of ankylosing spondylitis","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0410","first-page":"621","article-title":"Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity","volume":"77","author":"Ugur","year":"2015","journal-title":"Nagoya J. Med. Sci."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0415","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/keu382","article-title":"IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities","volume":"54","author":"Jansen","year":"2014","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0420","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.39464","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0430","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.014_bib0435","article-title":"The role of innate lymphoid cells in health and disease","author":"Mohammadi","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0440","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0445","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/eji.201545598","article-title":"Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice","volume":"45","author":"Montaldo","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0450","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/ar3351","article-title":"IL-17 in spondyloarthritis: is the T-party over?","volume":"13","author":"Yeremenko","year":"2011","journal-title":"Arthritis. Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0460","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrrheum.2012.205","article-title":"The role of IL-17-secreting mast cells in inflammatory joint disease","volume":"9","author":"Kenna","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0465","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","article-title":"Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?","volume":"24","author":"Ambarus","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0470","first-page":"731","article-title":"\u2018MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease, Nature reviews","volume":"11","author":"McGonagle","year":"2015","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0475","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"7351","key":"10.1016\/j.imlet.2018.01.014_bib0480","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0485","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijmm.2009.08.011","article-title":"Innate antimicrobial host defense in small intestinal Crohn's disease","volume":"300","author":"Koslowski","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.imlet.2018.01.014_bib0490","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1038\/mi.2008.48","article-title":"Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease","volume":"1","author":"Wehkamp","year":"2008","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0495","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/gut.2007.142588","article-title":"Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease","volume":"57","author":"Simms","year":"2008","journal-title":"Gut"},{"issue":"5778","key":"10.1016\/j.imlet.2018.01.014_bib0500","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Sci. (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0505","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol."},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0510","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1111\/j.1462-2920.2009.01982.x","article-title":"Towards the human intestinal microbiota phylogenetic core","volume":"11","author":"Tap","year":"2009","journal-title":"Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0515","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/embor.2012.68","article-title":"The changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health","volume":"13","author":"Hunter","year":"2012","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0520","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39259","article-title":"Microbiome in inflammatory arthritis and human rheumatic diseases","volume":"68","author":"Scher","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0525","first-page":"260","article-title":"The human microbiome: at the interface of health and disease, Nature reviews","volume":"13","author":"Cho","year":"2012","journal-title":"Genetics"},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0530","first-page":"411","article-title":"Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut, Nature reviews","volume":"8","author":"Artis","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0535","first-page":"27","article-title":"Microbiota restoration: natural and supplemented recovery of human microbial communities, Nature reviews","volume":"9","author":"Reid","year":"2011","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.imlet.2018.01.014_bib0540","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/35.12.1314","article-title":"The arthritis of coeliac disease: prevalence and pattern in 200 adult patients","volume":"35","author":"Lubrano","year":"1996","journal-title":"Br. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0545","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1039\/C6FO00831C","article-title":"Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota","volume":"7","author":"Tian","year":"2016","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0550","first-page":"128","article-title":"Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives","volume":"26","author":"Vaile","year":"1999","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0555","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","article-title":"Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives","volume":"33","author":"Martinez-Gonzalez","year":"1994","journal-title":"Br. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/BOR.0000000000000296","article-title":"Intestinal dysbiosis and innate immune responses in axial spondyloarthritis","volume":"28","author":"Ciccia","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0565","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0570","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kev245","article-title":"Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation","volume":"55","author":"Wright","year":"2016","journal-title":"Rheumatol. (Oxford, England)"},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0575","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clim.2015.05.001","article-title":"Gut microbes, immunity, and spondyloarthritis","volume":"159","author":"Stoll","year":"2015","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0580","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","article-title":"The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses","volume":"31","author":"Gaboriau-Routhiau","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.imlet.2018.01.014_bib0585","doi-asserted-by":"crossref","first-page":"e105684","DOI":"10.1371\/journal.pone.0105684","article-title":"HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.imlet.2018.01.014_bib0590","first-page":"1542","article-title":"Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histologyA prospective study","volume":"18","author":"Mielants","year":"1991","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0595","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni.1825","article-title":"Enteric defensins are essential regulators of intestinal microbial ecology","volume":"11","author":"Salzman","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0600","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"issue":"6015","key":"10.1016\/j.imlet.2018.01.014_bib0605","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.imlet.2018.01.014_bib0610","doi-asserted-by":"crossref","first-page":"872632","DOI":"10.1155\/2013\/872632","article-title":"The link between ankylosing spondylitis Crohn's disease, Klebsiella, and starch consumption","volume":"2013","author":"Rashid","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2018.01.014_bib0615","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF03342649","article-title":"The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis","volume":"15","author":"Ebringer","year":"1996","journal-title":"Clin. Rheumatol."},{"issue":"64","key":"10.1016\/j.imlet.2018.01.014_bib0620","first-page":"187","article-title":"Gut-mediated and HLA-B27-associated arthritis: an emphasis on ankylosing spondylitis and Crohn's disease with a proposal for the use of new treatment","volume":"12","author":"Rashid","year":"2011","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0625","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/rheumatology\/keg482","article-title":"Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis","volume":"43","author":"Stone","year":"2004","journal-title":"Rheumatol. (Oxford, England)"},{"issue":"2\u20133","key":"10.1016\/j.imlet.2018.01.014_bib0630","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(95)00760-7","article-title":"Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae","volume":"369","author":"Fielder","year":"1995","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0635","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0640","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0645","first-page":"356","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity, Nature reviews","volume":"14","author":"Alexander","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.imlet.2018.01.014_bib0650","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.2147\/DDDT.S111568","article-title":"Efficacy of an acquainted drug in the treatment of inflammatory low back pain: sulfasalazine under investigation","volume":"10","author":"Moghimi","year":"2016","journal-title":"Drug Design, Dev. Ther."},{"issue":"4","key":"10.1016\/j.imlet.2018.01.014_bib0655","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/SMJ.0b013e31802fa2a8","article-title":"Treatment of ankylosing spondylitis with moxifloxacin","volume":"100","author":"Ogrendik","year":"2007","journal-title":"South. Med. J."},{"issue":"11","key":"10.1016\/j.imlet.2018.01.014_bib0660","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U","article-title":"Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli","volume":"43","author":"Nieuwenhuis","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"16","key":"10.1016\/j.imlet.2018.01.014_bib0665","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1007\/s00253-013-4875-0","article-title":"The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability","volume":"97","author":"Antoniani","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0670","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/jf990519i","article-title":"Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria","volume":"48","author":"Van Laere","year":"2000","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0675","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600240","article-title":"Probiotics, gut microbiota, and their influence on host health and disease","volume":"61","author":"Sanchez","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0680","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10875-010-9457-7","article-title":"Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor","volume":"31","author":"Amdekar","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0685","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.52.3.370","article-title":"Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment","volume":"52","author":"Dieleman","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0690","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI32639","article-title":"Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis","volume":"118","author":"Abdollahi-Roodsaz","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2018.01.014_bib0695","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-319-31248-4_10","article-title":"How to manipulate the microbiota: Fecal microbiota transplantation","volume":"902","author":"Fuentes","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imlet.2018.01.014_bib0700","first-page":"h6043","article-title":"Obstacles to establishing an NHS faecal transplant programme","volume":"351","author":"Mullish","year":"2015","journal-title":"BMJ (Clin. Res. ed.)"},{"issue":"16","key":"10.1016\/j.imlet.2018.01.014_bib0705","doi-asserted-by":"crossref","first-page":"e6479","DOI":"10.1097\/MD.0000000000006479","article-title":"Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis","volume":"96","author":"Uygun","year":"2017","journal-title":"Med. (Baltimore)"},{"issue":"1","key":"10.1016\/j.imlet.2018.01.014_bib0710","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","article-title":"Fecal microbiota transplantation broadening its application beyond intestinal disorders","volume":"21","author":"Xu","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.imlet.2018.01.014_bib0715","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.imlet.2018.01.014_bib0720","first-page":"1363","article-title":"Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders","volume":"17","author":"Balato","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"9","key":"10.1016\/j.imlet.2018.01.014_bib0725","first-page":"585","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing, Nature reviews","volume":"14","author":"Gaffen","year":"2014","journal-title":"Immunology"},{"issue":"9906","key":"10.1016\/j.imlet.2018.01.014_bib0730","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"26","key":"10.1016\/j.imlet.2018.01.014_bib0735","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in Ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.imlet.2018.01.014_bib0740","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/annrheumdis-2016-210023","article-title":"Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study","volume":"76","author":"Sieper","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.imlet.2018.01.014_bib0745","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2018.01.014_bib0750","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn\u2019s disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2018.01.014_bib0755","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/13543784.2017.1337744","article-title":"Developments with experimental and investigational drugs for axial spondyloarthritis","volume":"26","author":"Clavel","year":"2017","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817305709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817305709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T22:38:51Z","timestamp":1719787131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817305709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":151,"alternative-id":["S0165247817305709"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.01.014","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of gut microbiota and IL-23\/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}